respiratory diseases

Brinsupri
Pharma

Insmed's Brinsupri comes up short in rhinosinusitis trial

Insmed's shares tumbled by 16% when it reported the failure of a phase 2 trial of Brinsupri in chronic rhinosinusitis without nasal polyps.
Moderna

Moderna-backed campaign takes a shot at boosting vaccine uptake

Oct 22, 2025 12:30pm
CRL RTF rejection

Savara's lung disease asset hit with FDA refuse-to-file letter

May 27, 2025 10:35am
Italy Italian flag

Chiesi unveils €430M investment in new Italian inhaler facility

Mar 27, 2025 10:47am
COPD chronic obstructive pulmonary disease respiratory lungs

GSK posts COPD win for Nucala as rival nears possible approval

Sep 6, 2024 9:40am
Sketch of lungs

Jane Seymour backs Insmed's push to tackle gender and age biases

Mar 5, 2024 6:41am